Primary cilia are antenna-like sensory microtubule structures that extend from basal bodies, plasma membrane–docked mother centrioles. Cellular quiescence potentiates ciliogenesis, but the regulation of basal body formation is not fully understood. We used reverse genetics to test the role of the small calcium-binding protein, centrin2, in ciliogenesis. Primary cilia arise in most cell types but have not been described in lymphocytes. We show here that serum starvation of transformed, cultured B and T cells caused primary ciliogenesis. Efficient ciliogenesis in chicken DT40 B lymphocytes required centrin2. We disrupted CETN2 in human retinal pigmented epithelial cells, and despite having intact centrioles, they were unable to make cilia upon serum starvation, showing abnormal localization of distal appendage proteins and failing to remove the ciliation inhibitor CP110. Knockdown of CP110 rescued ciliation in CETN2-deficient cells. Thus, centrin2 regulates primary ciliogenesis through controlling CP110 levels.
Primary cilia are crucial for several signal transduction pathways (Goetz and Anderson, 2010). Their assembly is an ordered process that must be closely integrated with the cell cycle because of the dual roles of centrioles in ciliation and in mitosis (Sorokin, 1962; Seeley and Nachury, 2010; Ishikawa and Marshall, 2011). After cell division, a daughter cell inherits a centrosome that consists of pericentriolar material (PCM) in which are embedded two centrioles, barrel-shaped structures of triplet microtubules arranged with a ninefold symmetry. The centrioles differ from one another: the older of the two carries distal and subdistal appendages and is termed the mother centriole, as distinct from the younger, daughter centriole. During centrosome duplication in S phase, both centrioles will serve as the foundation for new procentrioles, although the daughter only acquires its appendages later in the cycle (Nigg and Stearns, 2011). These appendages are key to the plasma membrane recruitment of the mother centriole to serve as a basal body, the structure from which the ciliary axoneme extends in a membrane-bounded, nine-membered array of doublet microtubules.
Primary cilia are found in most cell types in the body but have not been described in lymphocytes. Although the reasons for a general lack of ciliation in lymphocytes are unclear, it is possible that this is related to the requirement of centrosomes for immune cell function. The movement of centrosomes toward the immune synapse, a membrane region at which cells of the immune system contact their target cells, helps to establish a specialized structure that has several similarities with cilia (Stinchcombe and Griffiths, 2014). Although no axoneme is formed at the immune synapse, several ciliary components have been implicated in immune synapse functions (Finetti et al., 2009), so that certain immune cell functions may not be compatible with the capacity for primary ciliogenesis (Griffiths et al., 2010). However, whether lymphocytes are capable of making cilia is an open question.
The mechanism that controls the functional change from centriole to basal body is not fully understood (Kobayashi and Dynlacht, 2011). A complex that includes CP110 and Cep97 acts as a cap at the distal end of centrioles to block mother centriole conversion to a basal body (Kleylein-Sohn et al., 2007; Spektor et al., 2007; Tsang et al., 2008). CP110 levels are regulated during the cell cycle by targeted degradation through the ubiquitin–proteasome system (D’Angiolella et al., 2010; Li et al., 2013), with TTBK2 (tau tubulin kinase 2) also being required for efficient removal of CP110 (Goetz et al., 2012; Čajánek and Nigg, 2014). Another interactor of CP110 is centrin2, a small, highly conserved calcium-binding protein, although the functional significance of this interaction in cilium regulation is unknown (Tsang et al., 2006). Although centrin plays a critical role in centriole dynamics and ciliogenesis in lower eukaryotes, its roles in vertebrate cells are less clear (Dantas et al., 2012). Here, we explore the roles of centrin2 in ciliogenesis using a series of chicken lymphocytes with targeted mutations in all the centrin genes (Dantas et al., 2011) as well as gene disruption in the ciliated RPE1 cell line.
Results and discussion
Exit from the cell cycle into quiescence has long been established as potentiating ciliogenesis (Dingemans, 1969; Seeley and Nachury, 2010). We tested whether the chicken DT40 lymphocyte cell line could be induced to undergo primary ciliation. Serum starvation of chicken B-lymphocyte DT40 cells led to cell cycle delay (Fig. 1, a and b) and a reproducible induction of primary cilia (Fig. 1, c and d). The ability to induce cilia in DT40 cells allowed us to explore the roles of centrin in ciliogenesis. Examining a series of genetically defined centrin knockout lines (Dantas et al., 2011), we found that centrin2 deficiency led to a significant decline in ciliation capacity that was as extensive as the decline seen in cells that lacked all three chicken centrin isoforms. Although the expression of centrin3 and centrin4 could partially rescue the absence of all chicken centrins in ciliogenesis, only the expression of centrin2 led to a complete rescue of the ability of DT40 cells to make primary cilia after serum starvation (Fig. 1 e), demonstrating that centrin2 is required for ciliation in lymphocytes. Centrin2 depletion in zebrafish gave rise to several ciliopathy phenotypes (Delaval et al., 2011) and a mouse knockout also revealed marked ciliopathy that was restricted to specific tissues (Ying et al., 2014). It was concluded that the murine phenotype in affected tissues was caused by problems in ciliary trafficking, with normal ciliogenesis initiation and axoneme formation (Ying et al., 2014). Given the partial rescue of ciliation that we see with centrin3 and centrin4 in the chicken model, it is possible that the interplay between the individual members of the centrin family determines the precise roles of an individual centrin in a given tissue.
As ciliogenesis has not been described in lymphocytes before, to our knowledge, we wished to confirm that we were observing bona fide cilia. We used serum starvation to induce ciliogenesis in human Jurkat T-lymphocytes and NALM-6 B cells. Culturing these lines in 0.5% serum, instead of the standard 10%, caused marked increases in their doubling times and cell cycle delays (Fig. 2, a and b). When we stained serum-starved Jurkat or NALM-6 cells with antibodies to acetylated tubulin, we reproducibly observed linear structures that resembled primary cilia (Fig. 2, c and d). The base of these structures contained centrioles, as determined by Cep135 and centrin3 staining, within apparently normal PCM, as visualized by pericentrin and γ-tubulin (Fig. 2 e). In addition, the established cilia markers IFT88, Arl13B, PDGFR-α, Gli2, Patched, and detyrosinated tubulin all localized to these structures (Fig. 2, f and g) and treatment of serum-starved NALM-6 cells with Smoothened agonist (SAG) led to the localization of Smoothened (Fig. 2 h), indicative of their functioning as cilia. Depletion of the negative ciliary regulator CP110 by siRNA treatment also induced these structures (Fig. 2, i and j), suggesting that their regulation is similar to that of primary cilia (Spektor et al., 2007). The structures induced by CP110 knockdown in lymphocytes did not contain centrin3, which was restricted to the basal body (Fig. 2 k), and were positive for the ciliary markers Arl13B and PDGFR-α (Fig. 2 l). Transmission EM (TEM) revealed the membrane association of the mother centriole, the nucleation of vesicles that resemble the ciliary pocket, and the extension of axoneme-like structures in CP110-depleted lymphocytes (Fig. 2 m). Along with the immunofluorescence microscopy of cilium-specific markers, the TEM data provide strong support for these being primary cilia, rather than the extended centrioles that have been described in nonciliating U2OS cells upon CP110 knockdown (Kohlmaier et al., 2009; Schmidt et al., 2009; Tang et al., 2009). Together, these data indicate that apparently normal, functional primary cilia can be induced in cultured lymphocytes, albeit with the obvious caveats that these are transformed cell lines and that the efficiency of this process is low. Although significant lymphocyte populations are quiescent for long periods and thus might be expected to use ciliation as a regulatory mechanism, whether lymphocytes make cilia in the body remains to be determined, especially given the additional roles required of the centrosomes in immune cell functioning (Stinchcombe and Griffiths, 2014).
To address the question of how centrin2 contributes to ciliogenesis in cells that normally form cilia, we used the CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 system of RNA-guided endonuclease activity to disrupt the sequence coding for centrin2 in the immortalized, nontransformed human telomerase reverse transcriptase (hTERT)–RPE1 cell line (Jinek et al., 2012). The guide RNAs were designed to target exon 4 of CETN2, which encodes the third of centrin’s four calcium-binding EF-hands (Fig. 3 a). Immunoblot and immunofluorescence microscopy screening identified a centrin-deficient clone (Fig. 3, b and c), and DNA sequence analysis confirmed two mutations that led to premature stop codons in the centrin2 coding sequence (Fig. 3 d). This null clone was used for our analysis (Fig. 3 b, clone 4). Centrin2-deficient cells showed no proliferation defect, even proliferating more rapidly than wild-type controls (Fig. 3 e). Wild-type RPE1 cells underwent high levels of ciliogenesis upon serum starvation, with >80% of cells carrying primary cilia, but <10% of centrin2-deficient cells made cilia under the same circumstances (Fig. 3, f and g). Previous work in hTERT-RPE1 cells using siRNA to deplete centrin2 also observed declines in ciliation capacity, albeit only to ∼40% of control levels, which may reflect technical differences between the analysis of null and knockdown cells (Graser et al., 2007; Mikule et al., 2007). Importantly, expression of centrin2 in our knockout cells restored their ciliation capacity to wild-type levels (Fig. 3 g).
Examining potential mechanisms for the ciliation defect in centrin2-deficient cells, we found that centrin2 ablation did not affect centriole or PCM integrity, as determined by microscopy of centrin3, pericentrin, and γ-tubulin (Fig. 3 h). PCM-1 staining indicated intact centriolar satellite formation in the absence of centrin2 (Fig. 3 i). However, we did observe marked alterations in the composition of the distal end of centrioles in centrin-deficient cells. As shown in Fig. 3 i, both centrioles carried Cep164, Cep170, and ninein, which are normally limited to the mother centriole, with a marked dispersion of the Cep164 and ninein signals away from their normal localization at the distal end of the centrioles (Ou et al., 2002; Graser et al., 2007). Although we observed centriolar localization of TTBK2 and IFT88, these were not incorporated into ciliary structures (Fig. 3 j). Furthermore, we did not observe any Arl13b at centrioles, confirming the absence of ciliary function in centrin2-deficient cells (Fig. 3 j). These observations suggested that the principal defect in centrin2 nulls lies at the distal end of the centriole and, thus, in the potential for converting centrioles to basal bodies.
TEM confirmed the integrity of the centrioles in centrin2-deficient cells (Fig. 4 a). This analysis also demonstrated that centrioles docked successfully with ciliary vesicles, a key early step in ciliogenesis that is directed by Cep164 (Fig. 4 a; Sorokin, 1962; Schmidt et al., 2012; Tanos et al., 2013). Despite the abnormal Cep164 distribution that we saw in centrin-deficient cells, this observation indicates that the distal appendages are capable of allowing docking and that the defect in ciliation lies at a later stage in the process.
After docking, the extension of the centriole into the vesicle forms the ciliary axoneme (Sorokin, 1962; Schmidt et al., 2012). Centrin2-deficient cells did not carry out this step. A crucial requirement for axoneme outgrowth is the removal of CP110 and its partner protein, Cep97, from the distal end of the mother centriole (Spektor et al., 2007; Tsang et al., 2008). CP110 was present at both centrioles in cycling wild-type and centrin2-deficient cells and was then lost from the wild-type mother centriole upon cilium induction by serum starvation (Fig. 4 b). Notably, this removal of CP110 did not occur in centrin2-null cells, with cells instead acquiring multiple foci of CP110 around the centrioles (Fig. 4 b). Similarly, Cep97 was not removed from the mother centriole, but, in fact, its signal increased around the centrioles (Fig. 4 c). The CP110 signals now colocalized with centriolar satellites (Fig. 4 d), suggesting a marked alteration of CP110 dynamics in the absence of centrin2. Although serum starvation of wild-type cells led to a decline in cellular levels of CP110 and Cep97, centrin2-deficient cells maintained high levels of both proteins (Fig. 4 e). Interestingly, serum starvation induced a notable increase in centrin2 levels. An increase in p16 levels was seen in response to serum starvation in both wild-type and centrin2-deficient cells, indicating that centrin2 loss did not blunt general cellular responses to nutrient deprivation (Fig. 4 e). Although recent work has indicated that autophagy regulates primary cilium formation (Pampliega et al., 2013; Tang et al., 2013), we found no effect of centrin2 deficiency on cellular levels of the autophagy-regulating E3 ligase, Atg5, or the autophagy substrate, LC3B, suggesting this is not the primary mechanism by which centrin2 regulates ciliation (Fig. 4 e). We next tested whether the ciliary defect in centrin2 knockout cells could be attributed solely to CP110 dysregulation by depleting CP110 using siRNA. As shown in Fig. 4 (f–h), CP110 knockdown rescued primary ciliation in serum-starved centrin2-deficient cells, demonstrating that CP110 removal is the key activity mediated by centrin2 in allowing ciliation.
One mechanism that regulates CP110 removal acts through TTBK2 at basal bodies, although the relevant targets of this kinase are not yet defined (Goetz et al., 2012; Čajánek and Nigg, 2014). While TTBK2 localized to centrin2-deficient centrioles, its asymmetric recruitment to the mother centriole was lost (Fig. 3 j). One way centrin2 might regulate CP110 may be through the localization of TTBK2 and Cep164, given the reported interactions of these proteins (Čajánek and Nigg, 2014). Another mechanism that removes CP110 involves its ubiquitination and subsequent degradation through the ubiquitin ligase complex SCFcyclin F (D’Angiolella et al., 2010), an activity that is opposed by the deubiquitinating enzyme USP33 (Li et al., 2013). We found that serum starvation led to a marked reduction in cyclin F levels in both wild-type and centrin2-deficient cells but that there was a greater decline in cyclin F levels in centrin2-null cells (Fig. 4 i), suggesting another possibility for how centrin deficiency may impede the removal of CP110 from centrioles. Therefore, the regulation of TTBK2 localization or activity, as well as the control of cyclin F activity at the distal end of the centriole, both remain as potential mechanisms by which centrin2 directs CP110 removal to permit ciliogenesis.
Materials and methods
Cells and cell culture
All human cell lines were maintained in a humidified 5% CO2 atmosphere at 37°C. Jurkat E6.1 human T cells were obtained from Sigma-Aldrich; NALM-6 human B cells were obtained from the Leibniz Institute-German Collection of Microorganisms; and hTERT-RPE1 cells were obtained from ATCC. Jurkat and NALM-6 cells were grown in RPMI 1640 (Gibco) supplemented with 10% vol/vol FBS (Sigma-Aldrich) and penicillin-streptomycin (100 U/ml and 100 µg/ml, respectively; Sigma-Aldrich). hTERT-RPE1 cells were grown in DMEM/F12 1:1 (Lonza) supplemented with 10% FBS and penicillin-streptomycin. Chicken DT40 B cells were maintained in a humidified 5% CO2 atmosphere at 39.5°C. The DT40 single Cetn2−/−, Cetn3−, and Cetn4−/− and triple Cetn4−/− Cetn2−/− Cetn3− knockouts were generated using gene targeting (Dantas et al., 2011, 2013). Stable transfection into the triple Cetn4−/− Cetn2−/− Cetn3− knockouts of plasmids that expressed myc-Cetn2, GFP-Cetn3, and myc-Cetn4 under the control of the cytomegalovirus promoter in pCMV-3tag or pEGFP-C1 gave the centrin rescue cell lines previously described (Dantas et al., 2011). DT40 cells were grown in RPMI 1640 supplemented with 10% FBS, 1% vol/vol chicken serum (Sigma-Aldrich), and penicillin-streptomycin. For serum starvation experiments, Jurkat cells were plated at 0.2 × 106 cells/ml in RPMI 1640 media supplemented with 0.5% FBS for 72 h; NALM-6 cells were plated at 0.75 × 106 cells/ml in RPMI 1640 media supplemented with 0.5% FBS for 100 h; and DT40 cells were plated at 0.15 × 106 cells/ml in RPMI 1640 media supplemented with 0.5% FBS and 1% chicken serum for 48 h. Primary cilia formation was induced in hTERT-RPE1 cells by culturing cells in DMEM/F12 supplemented with 0.1% FBS for up to 48 h. To deplete cells of serum, cells were washed twice with PBS followed by two washes with reduced serum media before being plated in fresh reduced serum media for the duration of the experiment. The SAG (CAS 364590–63-6; EMD Millipore) was used at 100 nM for 4 h to induce movement of Smoothened into the primary cilium.
CRISPR/Cas9 targeting of
CETN2 in hTERT-RPE1 cells
RNA-guided targeting of CETN2 in hTERT-RPE1 cells was achieved through coexpression of the Cas9 protein with guide RNAs. A guide RNA expression plasmid was generated by inserting annealed primers into the pX333-U6-Chimeric_BB-CBh-hSpCas9 vector (plasmid 43330; Addgene; deposited by F. Zhang, Massachusetts Institute of Technology, Cambridge, MA; Cong et al., 2013) digested by BbsI. Primers targeting exon 4 were designed based on the human exome Cas9 site catalogs (Mali et al., 2013): forward primer 5′-CACCGGTTCAAAAATCTGAAACGCG-3′ and reverse primer 5′-AAACCGCGTTTCAGATTTTTGAACC-3′. For transfection, 3 µg plasmid DNA was complexed with Lipofectamine 2000 (Invitrogen) in serum-free OptiMEM (Gibco) according to the manufacturer’s instructions and added to cells at 70% confluency. The following day, the transfected cells were serially diluted, and individual colonies were picked and expanded 10 d later. Screening of CETN2 protein levels by Western blotting and immunofluorescence microscopy was used to confirm loss of protein expression. Genomic DNA was extracted and subjected to PCR using a forward primer to intron 3, 5′-CCGCAAGTCTAGACTCGAG-3′, and reverse primer to intron 4, 5′-CCTTGAAGATTGCCTTGACTAG-3′, to generate a product spanning the targeted region. The PCR product was cloned into pGEM-T-Easy (Promega), and DNA was prepared from individual bacterial colonies and sent for commercial sequencing.
Silencer Select siRNA oligonucleotides specific to CP110 (#1 sense, 5′-GCAAAACCAGAAUACGAGATT-3′, and antisense, 5′-UCUCGUAUUCUGGUUUUGCAT-3′; and #2 sense, 5′-CAAGCGGACUCACUCCAUATT-3′, and antisense, 5′-UAUGGAGUGAGUCCGCUUGAG-3′) or GAPDH as an experimental control (sense, 5′-UGGUUUACAUGUUCCAAUATT-3′, and antisense, 5′-UAUUGGAACAUGUAAACCATG-3′) were purchased from Ambion. For suspension cells, 50 nmol siRNA was transfected using Amaxa Nucleofector Kit V (Jurkat) or Kit T (NALM-6) according to the manufacturer’s instructions (Lonza). Cells were analyzed by Western blotting and immunofluorescence microscopy 72 h (Jurkat) or 100 h (NALM-6) after transfection. For hTERT-RPE1 cells, 50 nmol siRNA was complexed with Oligofectamine (Invitrogen) in serum-free OptiMEM (Gibco) according to the manufacturer’s instructions. 24 h after transfection, cells were serum starved as described for 24 h before analysis by Western blotting and immunofluorescence microscopy.
For transient rescue experiments pCETN2-GFP (Inanç et al., 2010) was transfected into CETN2-null hTERT-RPE1 cells. 1 µg plasmid DNA was complexed with Lipofectamine 2000 in serum-free OptiMEM and added to cells at 60% confluency. 24 h after transfection, cells were serum starved as described for 24 h before analysis by immunofluorescence microscopy.
Adherent cells (hTERT-RPE1) were grown on glass coverslips while suspension cells (Jurkat, NALM-6, and DT40) were attached to poly-l-lysine–coated slides for 10 min at 4°C. Cells were fixed in methanol/5 mM EGTA at −20°C for 10 min or 4% paraformaldehyde for 7 min at room temperature followed by permeabilization with 0.15% Triton X-100 in PBS for 30 s. Before fixation and staining with acetylated tubulin, cells were incubated on ice for 30 min to depolymerize microtubules. The cells were blocked in 1% BSA in PBS and incubated with primary antibodies for 1 h at room temperature followed by a 45-min incubation with secondary antibodies. Donkey secondary antibodies were labeled with Alexa Fluor 488, Alexa Fluor 594, or Rhodamine (Jackson ImmunoResearch Laboratories, Inc.). DNA was stained with Hoechst 33258 (Sigma-Aldrich). Slides were mounted with 3% wt/vol N-propyl-gallate and 80% vol/vol glycerol in PBS. Images were captured with a camera (Orca AG; Hamamatsu Photonics) under oil at room temperature on a microscope (IX71; Olympus), 100× oil objective, NA 1.35, using Volocity software (PerkinElmer), and merges and individual channel images were exported as TIFFs for publication. Images were then cropped for publication using Photoshop CS6 (Adobe). Mouse monoclonal antibodies used were as follows: acetylated tubulin (1:2,000; T6793; Sigma-Aldrich), γ-tubulin (1:1,000; T6557; Sigma-Aldrich), and Centrin3 (1:1,000; 3E6; Abnova). Rabbit polyclonal antibodies used were against γ-tubulin (1:1,000; T3559; Sigma-Aldrich), Cep135 (1:1,000; ab75005; Abcam), Pericentrin (1:1,000; ab4448; Abcam), Centrin2 (1:500; 6288; BioLegends), Ninein (1:200; ab4447; Abcam), Cep164 (1:250; NBP1-77006; Novus Biologicals), Cep170 (1:1,000; raised against His-tagged amino acids 15–754 of human Cep170, a gift from G. Guarguaglini, University of Rome, Rome, Italy; Guarguaglini et al., 2005), PCM-1 (1:1,000; raised against His-tagged amino acids 1,665–2,024 of the human PCM-1, a gift from A. Merdes, University of Toulouse, Toulouse, France; Dammermann and Merdes, 2002), CP110 (1:500; 12780–1-AP; Proteintech), Arl13b (1:500; 17711–1-AP; Proteintech), IFT88 (1:800; 13967–1-AP; Proteintech), Gli2 (1:200; sc-28674; Santa Cruz Biotechnology, Inc.), PDGFR-α (1:200; sc-338; Santa Cruz Biotechnology, Inc.), detyrosinated tubulin (1:800; ab48389; Abcam), and Smoothened (1:500; ab38686; Abcam). Goat polyclonal antibodies used were against PCM-1 (1:1,000, for costaining with CP110; sc-50164; Santa Cruz Biotechnology, Inc.), Patched (1:200; sc-6149; Santa Cruz Biotechnology, Inc.), and TTBK2 (1:500; sc-165430; Santa Cruz Biotechnology, Inc.).
Whole-cell extracts were prepared with radioimmunoprecipitation assay buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, and 1 mM EDTA, with protease and phosphatase inhibitor cocktails). Extracts were boiled in loading buffer for 5 min. Proteins were separated on 10 or 15% SDS-PAGE gels and transferred to nitrocellulose membranes (GE Healthcare) for analysis. Blots were detected by ECL (GE Healthcare). Primary antibodies used were rabbit polyclonals against Atg5 (1:500; NB110-53818; Novus Biologicals), Centrin2 (1:1,000; 6288; BioLegends), CP110 (1:2,000; 12780–1-AP; Proteintech), Cep97 (1:5,000; 22050–1-AP; Proteintech), Cyclin F (1:1,000; sc-952; Santa Cruz Biotechnology, Inc.), and LC3B (1:500; 2775; Cell Signaling Technology); rabbit monoclonal against GAPDH (1:10,000; 2118; Cell Signaling Technology); and mouse monoclonals against α-tubulin (1:10,000; T5168; Sigma-Aldrich), and p16 (1:1,000; sc-56330; Santa Cruz Biotechnology, Inc.). HRP-conjugated goat anti–mouse or anti–rabbit secondary antibodies were used at 1:5,000 (Jackson ImmunoResearch Laboratories, Inc.). Band quantitation was performed using ImageJ version 1.48 (National Institutes of Health).
For flow cytometry, cells were fixed with ice-cold 70% ethanol at −20°C overnight. After fixation, cells were washed twice with PBS then resuspended in PBS containing 200 µg/ml RNase A and 40 µg/ml propidium iodide. Cytometry was performed on a FACSCanto (BD).
Cells were pelleted at 250 g for 5 min, washed twice with PBS, and then twice with 0.1 M sodium cacodylate buffer, pH 7.2 (Sigma-Aldrich), before primary fixation in 2% glutaraldehyde and 2% paraformaldehyde (Electron Microscopy Sciences) in cacodylate buffer overnight at 4°C. Cells were then secondarily fixed in 2% osmium tetroxide (Sigma-Aldrich) in cacodylate buffer for 2 h at room temperature. The cell pellet was then dehydrated through an ethanol gradient (30, 60, 90, and 100%) followed by propylene oxide. Subsequently, cells were embedded in Low Viscosity Resin (TAAB). Sections were cut on a microtome (Reichert-Jung Ultracut E; Leica), stained with uranyl acetate and lead citrate, and then viewed on a transmission electron microscope (H-7000; Hitachi). Images were taken with a camera (ORCA-HRL; Hamamatsu Photonics) and processed using AMT version 6 (AMT Imaging).
We thank Pierce Lalor at the National Biophotonics and Imaging Platform Ireland for technical assistance with the TEM, Tiago Dantas for cell lines, and Elaine Dunleavy for comments on the manuscript.
A Higher Education Authority PRTLI4 grant supported the National Biophotonics and Imaging Platform Ireland. This work was funded by the Science Foundation Ireland Principal Investigator award 10/IN.1/B2972.
The authors declare no competing financial interests.